Rodger Tiedemann

Senior Scientist @PMResearch_UHN
Consultant Hematologist @pmcancercentr
Assoc. Prof. University of Toronto
MBChB PhD FRACP FRCPA.
Science and coffee fan

[Rodger Tiedemann @Dr_Rodg]

Advocating for better medicines access in New Zealand. The Govt's arbitrary spending limit on medicines (at approx 1/3rd that of comparable nations) is strangling healthcare delivery for Kiwis. https://t.co/MUDDmCas77

[Jake Shortt @JakeShortt3]

Breaks my heart reading stories like this from a country I love. This poor chap can’t access proven, standard of care therapy for myeloma in NZ. The gulf between life saving medicines access either side of the Tasman just gets wider and wider…. https://t.co/8NePhTtoym

[Myeloma New Zealand @MyelomaNZ]

Myeloma families shouldn't have to be doing givealittles for medicines that are standard of care overseas. Please read the article - it includes comment on dara funding. https://t.co/yjCWod7JBG

[Rodger Tiedemann @Dr_Rodg]

@ninashah33 Thanks Nina for the super kind post.

I’m happy that there is an increasing acceptance that the way forward to cure involves eradicating these cells. Working together I’m optimistic that we can achieve that.

[Rodger Tiedemann @Dr_Rodg]

@gjmccaughan @MyelomaAust_MFA @MyelomaNZ Thanks Georgia! You’re so kind. It’s a pleasure to be back and am looking forward to working in the Australasian myeloma scene.

[Rodger Tiedemann @Dr_Rodg]

@adamcbest @BioBenBarwick Thinking that gun control won't reduce gun violence is like, I don't know.. like.. thinking that vaccines won't reduce disease.

[VJHemOnc @VJHemOnc]

#VJSessions | Leading experts @IreneGhobrial, Yael Cohen, @Dr_Rodg, and @EileenMBoyle discuss the use of single-cell analysis to tackle multiple myeloma.

Watch their exclusive roundtable discussion here:

👉https://t.co/mO2tGdO1Pr👈

#MMsm #HemOnc #Myeloma #ImmunoOnc

[Rodger Tiedemann @Dr_Rodg]

@gelarehzadeh @CCSResearch @PMResearch_UHN @emmagatt @niagaraonlake Just one of many Ben Neel era innovations that helped shape PM research and which contine to this day..

[Rodger Tiedemann @Dr_Rodg]

@gelarehzadeh @CCSResearch @PMResearch_UHN @emmagatt @niagaraonlake After 2 years of postponements the @PMResearch_UHN retreat was a huge success. Loved talking #science. @gelarehzadeh is an inspiration to me, as to many others. Was wonderful to catch up in person once again!

[VJHemOnc @VJHemOnc]

A great session focused on single-cell analysis with @IreneGhobrial @Dr_Rodg @EileenMBoyle and Yael Cohen!

#Myeloma2022 #MMsm #Myeloma #MultipleMyeloma

[Rodger Tiedemann @Dr_Rodg]

@shanmugamlab @BioBenBarwick I was converted by our 1q findings…OXPHOS is super important in myeloma and a potential target. Someone needs to do a trial.

[Rodger Tiedemann @Dr_Rodg]

@BioBenBarwick @shanmugamlab Thanks Ben! I was really happy to share this data. Now we just have to publish it..

[Brad Wouters 🇨🇦 @bradwouters]

With lack of meaningful case data wastewater is the best indicator of nee infections. Clear evidence we are over the peak in Ontario.

[Rodger Tiedemann @Dr_Rodg]

@AuclairDan Nice! Of course if you deleted TP53 and added KRAS the T cells would grow even better 😉

Me thinks a suicide gene or two may be needed.

[Nature Communications @NatureComms]

#Mouse models of #MultipleMyeloma and #scRNAseq reveal gene expression throughout tumour progression, drivers of #heterogeneity, and potential therapeutic targets
#CancerResearch by @PughLab @pmcancercentre @PMGenomics

@NatResCancer

https://t.co/3OvvmKMQdK

[Rodger Tiedemann @Dr_Rodg]

sciCNV: high-throughput paired profiling of transcriptomes and DNA copy number variations at single-cell resolution https://t.co/vr1L3bWNnL @scell_papers

[Rodger Tiedemann @Dr_Rodg]

Published today! Methods for dual profiling of DNA CNV and RNA in single cells. These improve (a) scRNA-seq normalization (b) CNV detection from RNA, enabling study of CNV effects on transcription at single cell level. https://t.co/cDaASnQx0b @PMResearch_UHN @SingleCellMedia

[Rodger Tiedemann @Dr_Rodg]

sciCNV: high-throughput paired profiling of transcriptomes and DNA copy number variations at single-cell resolution https://t.co/WI1OcuyL8S @Dr_Rodg

[Rodger Tiedemann @Dr_Rodg]

Meet our Community: Michal Moshkovich by @mishcwang https://t.co/Mrl7u38NI0

[Rodger Tiedemann @Dr_Rodg]

Delighted to report on the first highly selective GRK6 inhibitor. The fruits of a truly excellent collaboration with OICR. A paper that was long in the making. Thanks to all our co-authors.

[Rodger Tiedemann @Dr_Rodg]

Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma https://t.co/IXR9L1rrAQ